PRKCE and pancreatic neoplasm: The study reveals that 5-Lox inhibition blocks a PKCε-dependent survival mechanism, independent of Akt, emphasizing the significance of the 5-Lox pathway in controlling pancreatic cancer cell survival through PKCε signaling.